Bucher B, Neuburger J, Illes P
Laboratoire de Pharmacologie Cellulaire et Moléculaire, C.N.R.S. URA 600, Université Louis Pasteur Strasbourg, Illkirch, France.
J Cardiovasc Pharmacol. 1991 Jun;17(6):913-5. doi: 10.1097/00005344-199106000-00008.
In isolated rat tail arteries preincubated with [3H]noradrenaline, electrical field stimulation evoked the overflow of tritium. Phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activating phorbol ester, time-dependently increased the overflow at 1 mumol/L but not at 0.1 mumol/L. In contrast, the overflow was not altered by phorbol 13-acetate (PA, 1 mumol/L), which does not influence the activity of PKC. Polymyxin B (70 mumol/L), an inhibitor of PKC, depressed the overflow when given alone and, in addition, attenuated the effect of PMA, 1 mumol/L. The selective alpha 2-adrenoceptor agonist B-HT 933 depressed the overflow; PMA, 1 mumol/L, did not interfere with the effect of B-HT 933, 10 mumol/L. The results provide evidence for the participation of prejunctionally located PKC in the release of noradrenaline. However, PKC does not seem to be involved in the alpha 2-adrenoceptor-agonist-mediated inhibition of noradrenaline release.
在预先用[3H]去甲肾上腺素孵育的离体大鼠尾动脉中,电场刺激可诱发氚的溢出。佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA),一种激活蛋白激酶C(PKC)的佛波酯,在1μmol/L时可时间依赖性地增加溢出,但在0.1μmol/L时则无此作用。相比之下,佛波醇13-乙酸酯(PA,1μmol/L)不影响PKC的活性,对溢出没有影响。PKC抑制剂多粘菌素B(70μmol/L)单独使用时可降低溢出,此外,还可减弱1μmol/L PMA的作用。选择性α2-肾上腺素能受体激动剂B-HT 933可降低溢出;1μmol/L的PMA不干扰10μmol/L B-HT 933的作用。这些结果为接头前定位的PKC参与去甲肾上腺素释放提供了证据。然而,PKC似乎不参与α2-肾上腺素能受体激动剂介导的去甲肾上腺素释放抑制作用。